FDA Investigator Matthew G Brown
Matthew G Brown has conducted inspections on 68 sites in 1 countries as of 31 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
68
Last Inspection Date:
31 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Matthew G Brown:
Abdur Rashid,
Abraham M Maekele,
Adam J Williams,
Aigbokhai A Dirisu,
Alan R Moore,
Alaric C Denton,
Alexis S Roberts,
Alphonso A Haupt, III,
Amanda L Evanco,
Ana L Kewes,
Anthony S Puckett,
Antoinette L Chancey,
Arlyss M Jones,
Babatunde D Babalola,
Bonita S Chester,
Bruce R Burrell,
Carlos A Ortiz,
Carol F Robinson,
Chateryl K Washington,
Cheryl G Scott,
Christie B Rice,
Christopher C Wilcox,
Christopher S Keating,
Christopher T Smith,
Cierra S Strong,
Cordelia J Brammer,
David T Glover,
Davis,
Dawn M Braswell,
Dellarese L Herbert,
Derek C Price,
Douglas Brogden B,
Edward Deberry,
Esra Toussaint,
Eural E Porter,
Fulton A Varner,
Gabriel R Mclemore,
Gamal A Norton,
Heather Akleimola Hulbert,
Ibad U Khan,
Igbinoba,
Ingrid A Zambrana,
J Elkins,
Jackie M Douglas,
Jacqueline D Mitchell,
Jason K Morgan,
Jawaid Hamid,
Jeffrey D Sheppard,
Jerry T Hunt,
Jessica Fields,
John D Lloyd,
Johnetta F Walters,
Johnson,
Joseph F Owens,
Karen L Anderson,
Kathryn A Nagy,
Kenny R Robinson,
Kerry L Edwards, III,
Kimberly Cdelk Brooks,
Lakisha N Morton,
Lareese K Thomas,
Laurice Mccoy,
Lawrence Lawrence,
Lawrence S Newsom,
Lawrence Thomas,
Leo J Lagrotte,
Leroy M Anderson,
Leslie W Gilbert,
Lorenzo Jones,
Marcella D Crook,
Marie F Morin,
Miaja Umaedi,
Mokhless A Ghaly,
Myla D Chapman,
N'jere English,
Nancy E Fontaine,
Patricia F Hudson,
Paul W Moy,
Penny H Mccarver,
Renee J Wilkes,
Richard L Garcia,
Robert L Lewis, Jr,
Robert P Neligan,
Robert W Turner,
Robin N Goins,
Russell R Zablan,
Saeid E Kazan,
Sally Gopaul,
Sandra C Lawrence,
Sandra I Gaul,
Sarah C Pichette,
Sayeeda Hdabe,
Seneca D Toms,
Sheri S Oliver,
Simone E Hollis,
Simone M Edmonson,
Stardust W Mazzariello,
Susan M Taylor,
Susan O Oladeji,
Theresa L Stewart,
Thomas J Arista,
Tracy A Holloman,
Tyrico K English,
Vivian Garcia,
Young Kim
Matthew G Brown's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2007 | EIR | Americold Logistics, LLC - EIR, 2007-10-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more